AO

AOTI, Inc.

Provides at-home topical oxygen therapy for chronic wounds, reducing amputations and costs.

Overview

Corporate Details

ISIN(s):
US03690C1027
LEI:
213800ZGCNDSTWIRK687
Country:
United States of America
Address:
3512 SEAGATE WAY, STE 100, OCEANSIDE, 92056 OCEANSIDE
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

AOTI, Inc. (Advanced Oxygen Therapy Inc.) is a medical technology company focused on advanced wound care. It develops and commercializes Topical Wound Oxygen (TWO2) therapy, a multi-modality system for treating chronic and complex non-healing wounds, such as diabetic foot ulcers and venous leg ulcers. Designed for home use, the TWO2 system combines high-pressure topical oxygen, non-contact cyclical compression, and controlled humidity to promote durable healing. The company's therapy is supported by extensive clinical evidence, including randomized controlled trials, showing it reduces hospitalizations, amputations, and overall healthcare costs while enhancing patient access to care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-22 08:00
Earnings Release
2025 Interim Results
English 214.8 KB
2025-09-08 08:00
Report Publication Announcement
Notice of Results
English 12.6 KB
2025-09-03 08:00
Regulatory News Service
NICE fast track recommendation for Topical Oxygen
English 17.4 KB
2025-08-04 08:00
Director's Dealing
Director/PDMR Shareholding
English 22.2 KB
2025-08-01 11:03
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-07-31 12:02
Director's Dealing
Director/PDMR Shareholding
English 23.0 KB
2025-07-21 08:00
Regulatory News Service
California Medicaid Provider ID Awarded
English 13.6 KB
2025-03-25 18:59
Director's Dealing
Director/PDMR Shareholding
English 24.9 KB

Automate Your Workflow. Get a real-time feed of all AOTI, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AOTI, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AOTI, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Audientes A/S Logo
Develops smart, self-fitting, and affordable hearing aids for adults with hearing loss.
Denmark AUDNTS
Bactiguard Holding Logo
Licenses a patented coating to MedTech partners to prevent medical device infections.
Sweden BACTI
BBS-Bioactive Bone Substitutes Oyj Logo
Developed a bioactive bone graft substitute for orthopedic surgery before filing for bankruptcy.
Finland BONE
BELLUSCURA PLC Logo
Develops portable oxygen concentrators for patients needing supplemental oxygen.
United Kingdom BELL
BENO TNR, Inc. Logo
A diversified firm in biotech, wearable robotics, and eco-friendly building materials.
South Korea 206400
BibbInstruments AB Logo
Develops electric endoscopic biopsy tools for accurate cancer diagnosis in GI, lung, and urology.
Sweden BIBB
BIOBIJOU Co., Ltd. Logo
Develops and manufactures injectable aesthetic solutions like HA fillers for global markets.
South Korea 489460
Biocartis Group NV Logo
Develops an automated PCR platform for fast molecular diagnostics in oncology & infectious diseases.
Belgium BCART
Biocorp Logo
Develops and manufactures connected drug delivery systems and medical devices for pharma.
France ALCOR
BIODYNE CO., LTD. Logo
Develops automated liquid-based cytology systems and reagents for cancer diagnostics.
South Korea 314930

Talk to a Data Expert

Have a question? We'll get back to you promptly.